NCT03060551View on ClinicalTrials.gov

Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Systemic Sclerosis
Interventions
PROCEDURE

SVF injection

SVF is increasingly recognised as an easily accessible source of regenerative cells with therapeutic potential in ischaemic or autoimmune disease. We aimed to measure for the first time the safety, tolerability and potential efficacy of autologous SVF cells local injections in patients with systemic sclerosis

Trial Locations (1)

Unknown

Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul

All Listed Sponsors
lead

Suk-Ho Moon

OTHER

NCT03060551 - Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients | Biotech Hunter | Biotech Hunter